# Aripiprazole

## Abilify Maintena inj 400mg

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | IABI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Indications        | Bipolar I disorder， Schizophrenia，                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Dosing             | 400 mg once monthly (doses should be separated by more than 26 days); Tolerability should be established using oral aripiprazole prior to initiation of parenteral therapy; due to the half-life of oral aripiprazole it may take up to 2 weeks to fully assess tolerability. Continue oral aripiprazole (or other oral antipsychotic) for 14 days during initiation of parenteral therapy.                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Hypersensitivity to aripiprazole or any component of the formulation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | Headache， asthenia， accidental injury， peripheral edema， hypertension， GI disturbances， myalgia， agitation， anxiety， insomnia， lightheadedness， somnolence， akathisia， extrapyramidal syndrome， tremor， increased salivation， rhinitis， pharyngitis， coughing， blurred vision. Endocrine metabolic: Weight increased (2% to 30% ) Gastrointestinal: Constipation (5% to 11% )， Nausea (8% to 15% )， Vomiting (3% to 11% ) Neurologic: Akathisia (2% to 25% )， Dizziness (4% to 10% )， Extrapyramidal disease (2% to 27.3% )， Headache (12% to 27% )， Insomnia (8% to 18% )， Sedated (1% to 8% )， Somnolence (5% to 26.3% )， Tremor (2% to 11.8% ) Ophthalmic: Blurred vision (3% to 8% ) Psychiatric: Anxiety (4% to 17% )， Restlessness (2% to 12% ) Other: Fatigue (2% to 11% ) |
| Pregnancy          | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

## Abilify 5mg

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OABI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Indications        | Schizophrenia in adults & adolescents 13-17 years. Monotherapy or adjunctive therapy to either lithium or valproate for the acute manic & mixed episodes associated with Bipolar I disorder in adults & pediatrics 10-17 years. Adjunctive treatment of major depressive disorders. Irritability associated with autistic disorder in pediatric patients 6-17 years.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Dosing             | Schizophrenia: Adults: 10mg or 15mg QD. Effective range: 10-30 mg/day. Do not increase the dose until the course of treatment is up to 2 weeks. Teenagers， 13-17 years old: The initial daily dose is 2 mg， and it will be adjusted to 5 mg after 2 days， and then adjusted to the target dose of 10 mg after another 2 days. Bipolar disorder manic episodes and mixed episodes: Adults: 15mg QD. The initial dose for adjuvant therapy of lithium or valproate is 10-15 mg/day. Can be increased to 30 mg/day based on clinical response. Children， 10-17 years old: The initial daily dose is 2 mg， and adjusted to 5 mg after 2 days， and then adjusted to the target dose of 10 mg after another 2 days. If necessary after the adjustment， the dose should be increased by 5 mg each time. Adjuvant treatment of major depression: Adults: Inintial dose:2-5mg/day， titrate the dose to 10 mg/day or 15 mg/day in a manner not exceeding 5 mg/day each time. The adjustment interval should be more than 1 week. Tourette syndrome， 6~18 years old: <50kg: The initial dose is 2 mg per day， and the target dose of 5 mg/day will be reached after two days. In patients whose tics are not well controlled， the dose can be increased to 10 mg/day. The dosage should be adjusted step by step not to exceed 5 mg/day each time， and the interval should not be less than 1 week. >50kg: The initial dose is 2 mg/day for 2 days， then the dose is increased to 5 mg/day for 5 days， and the target dose is 10 mg/day on the 8th day. In patients whose tics are not well controlled， the dose can be increased to 20 mg/day. The dose should be adjusted step by step not to exceed 5 mg/day each time， and the interval should not be less than 1 week. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Known hypersensitivity to aripiprazole.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | Headache， asthenia， accidental injury， peripheral edema， hypertension， GI disturbances， myalgia， agitation， anxiety， insomnia， lightheadedness， somnolence， akathisia， extrapyramidal syndrome， tremor， increased salivation， rhinitis， pharyngitis， coughing， blurred vision. Endocrine metabolic: Weight increased (2% to 30% ) Gastrointestinal: Constipation (5% to 11% )， Nausea (8% to 15% )， Vomiting (3% to 11% ) Neurologic: Akathisia (2% to 25% )， Dizziness (4% to 10% )， Extrapyramidal disease (2% to 27.3% )， Headache (12% to 27% )， Insomnia (8% to 18% )， Sedated (1% to 8% )， Somnolence (5% to 26.3% )， Tremor (2% to 11.8% ) Ophthalmic: Blurred vision (3% to 8% ) Psychiatric: Anxiety (4% to 17% )， Restlessness (2% to 12% ) Other: Fatigue (2% to 11% )                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Pregnancy          | Human data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

